Abdominal obesity and metabolic syndrome
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome is associated with abdominal obesity, blood lipid disorders, inflammation, insulin resistance or full-blown diabetes, and increased risk of developing cardiovascular disease. Proposed criteria for identifying patients with metabolic syndrome have contributed greatly to preventive medicine, but the value of metabolic syndrome as a scientific concept remains controversial. The presence of metabolic syndrome alone cannot predict global cardiovascular disease risk. But abdominal obesity - the most prevalent manifestation of metabolic syndrome - is a marker of 'dysfunctional adipose tissue', and is of central importance in clinical diagnosis. Better risk assessment algorithms are needed to quantify diabetes and cardiovascular disease risk on a global scale.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is strongly linked to visceral fat accumulation around abdominal organs, disrupting normal endocrine functions more than subcutaneous fat (Dam et al., 2016; Després & Lemieux, 2006).”
From Long-term cardiometabolic effects of early institutionalization and foster care: Evidence from the Bucharest Early Intervention Project (2026) · cites this paper as Després & Lemieux, 2006
In the citing paper
“Alarmingly, obesity is known to pose a more substantial health hazard than the other CMD risks [19,20,21].”
In the citing paper
“Most tests of Fe status, however, are affected in response to subclinical inflammation and infections (690 -692) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [691]
In the citing paper
“The results of the present study contradict the prevailing dogma that VAT has deleterious metabolic effects (5,6).”
From Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity (2009) · cites this paper as [6]
In the citing paper
“The metabolic syndrome is a cluster of coronary heart disease risk factors-central obesity, hypertension, dyslipidemia, and glucose intolerance-that share an association with insulin resistance, which appears to be the primary underlying pathophysiologic disturbance (1).”
From Eating Meals Irregularly: A Novel Environmental Risk Factor for the Metabolic Syndrome (2008) · cites this paper as [1]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“In obesity, there is evidence of macrophage infiltration in adipose tissu”
BackgroundPrediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · cited 1×
“It has also been argued that current risk-assessment algorithms such as the Framingham Heart Study calculator of coronary heart disease (CHD) ris”
MethodThe metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Research works printed but not linked: 3
- Lemieux, I. et al. Contribution of interleukin-6 and tumor necrosis factor-alpha to the elevated C-reactive protein levels found in abdominally obese men. Obes. Res. 9, 66S (2001).
- Beckley, E. T. New ADA initiative moves beyond 'metabolic syndrome'. 'Cardiometabolic risk' proposed as umbrella term for diabetes risk factors. DOC News 3, 1–3 (2006).
- Després, J. P. From CVD risk to cardiometabolic risk. Presented at the Symposium of the International Chair on Cardiometabolic Risk. XIV International Symposium on Atherosclerosis (Rome, 18–22 June 2006).
Cited by
Items 601–700 of 1,035
Dikaiakou, E., Vlachopapadopoulou, E. A., Paschou, S. Α., Athanasouli, F., Panagiotopoulos, Ι., Kafetzi, M. L., Fotinou, A., & Michalacos, S. (2020) · Endocrine · doi:10.1007/s12020-020-02374-6 · Cited by 94
“ultimately lead to type 2 diabetes mellitus (T2DM) development [2].”
BackgroundCircadian Expression of Adiponectin and Its Receptors in Human Adipose Tissue
Gómez-Abellán, P., Gómez-Santos, C., Madrid, J. A., Milagro, F. I., Campion, J., Martínez, J. A., Ordovás, J. M., & Garaulet, M. (2010) · Endocrinology · doi:10.1210/en.2009-0647 · Cited by 93
“similar population (21) and could be associated with the cardioprotective feature of this adipose area, termed by some authors as healthy adipose tissue (22).”
BackgroundThe pathophysiology of abdominal adipose tissue depots in health and disease
Walker, G. E., Marzullo, P., Ricotti, R., Bona, G., & Prodam, F. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0023 · Cited by 90
“Between 10% and 20% of total body fat, a proportion that is lower in both adult and pediatric females [19, 20], is intra-abdominal or VAT that is found to be associated to the internal organs.”
Backgroundvan Eyk, H. J., Paiman, E. H. M., Bizino, M. B., de Heer, P., Geelhoed-Duijvestijn, P. H., Kharagjitsingh, A. V., Smit, J. W. A., Lamb, H. J., Rensen, P. C. N., & Jazet, I. M. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0890-5 · Cited by 90
Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study
Brahimaj, A., Rivadeneira, F., Muka, T., Sijbrands, E. J. G., Franco, O. H., Dehghan, A., & Kavousi, M. (2019) · Diabetologia · doi:10.1007/s00125-019-4921-2 · Cited by 98
Lv, Y., Qin, X., Jia, H., Chen, S., Sun, W., & Wang, X. (2019) · British Journal Of Nutrition · doi:10.1017/s0007114519001909 · Cited by 101
Li, S., Wang, L., Liu, B., & He, N. (2020) · Food & Function · doi:10.1039/c9fo02857a · Cited by 90
Gaida, J. E., Cook, J. L., & Bass, S. L. (2008) · Disability and Rehabilitation · doi:10.1080/09638280701786864 · Cited by 100
Maekawa, T., Jin, W., & Ishii, S. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00685-09 · Cited by 95
“type 2 diabetes mellitus, cancer, and heart disease (6, 23).”
BackgroundNanotoxicity: A Growing Need for Study in the Endocrine System
Lu, X., Liu, Y., Kong, X., Lobie, P. E., Chen, C., & Zhu, T. (2013) · Small · doi:10.1002/smll.201201517 · Cited by 90
Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements
Maneschi, E., Morelli, A., Filippi, S., Cellai, I., Comeglio, P., Mazzanti, B., Mello, T., Calcagno, A., Sarchielli, E., Vignozzi, L., et al. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0333 · Cited by 90
Miraglia del Giudice, E., Grandone, A., Cirillo, G., Santoro, N., Amato, A., Brienza, C., Savarese, P., Marzuillo, P., & Perrone, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027933 · Cited by 86
“Waist circumference is highly correlated with visceral adipose tissue and metabolic and cardiovascular risk factors in children, adolescents and adults [34,35].”
BackgroundMancuso, D. J., Sims, H. F., Yang, K., Kiebish, M. A., Su, X., Jenkins, C. M., Guan, S., Moon, S. H., Pietka, T., Nassir, F., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.115766 · Cited by 93
Wang, D. D., Bakhotmah, B. A., Hu, F. B., & Alzahrani, H. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106935 · Cited by 95
“This finding is not surprising given that insulin resistance is more strongly related to abdominal obesity than general obesity [30].”
BackgroundDe Souza, L. R., Berger, H., Retnakaran, R., Maguire, J. L., Nathens, A. B., Connelly, P. W., & Ray, J. G. (2016) · Diabetes Care · doi:10.2337/dc15-2027 · Cited by 84
“Proposed mechanisms underlying the pathological association between VAT and IR include free fatty acid release into the hepatic portal circulation (13,14).”
BackgroundRakotoarivelo, V., Lacraz, G., Mayhue, M., Brown, C., Rottembourg, D., Fradette, J., Ilangumaran, S., Menéndez, A., Langlois, M., & Ramanathan, S. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.03.004 · Cited by 98
“Excess visceral adiposity is associated with insulin resistance (IR), type 2 diabetes (T2D), atherosclerosis, hypertension and liver disorders (Despres and Lemieux, 2006).”
BackgroundAbdominal subcutaneous adipose tissue: a favorable adipose depot for diabetes?
Chen, P., Hou, X., Hu, G., Wei, L., Jiao, L., Wang, H., Chen, S., Wu, J., Bao, Y., & Jia, W. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0734-8 · Cited by 77
“Excess visceral adipose tissue was correlated with higher levels of free fatty acid overflow [2], inflammatory markers [28–31], and adipocytokines [32–34].”
BackgroundInfluentialLiu, Y., Retnakaran, R. R., Hanley, A. J., Tungtrongchitr, R., Shaw, C., & Sweeney, G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0890 · Cited by 89
Annuzzi, G., Piscitelli, F., Marino, L. D., Patti, L., Giacco, R., Costabile, G., Bozzetto, L., Riccardi, G., Verde, R., Petrosino, S., et al. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-43 · Cited by 98
Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity
Roberge, C., Carpentier, A. C., Langlois, M.-F., Baillargeon, J.-P., Ardilouze, J.-L., Maheux, P., & Gallo-Payet, N. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00516.2007 · Cited by 89
“Indeed, chronically elevated GC levels redistribute fat from subcutaneous depots to visceral adipose tissue (48), abdominal obesity being a critical feature of metabolic syndrome (55).”
Obesity, Insulin Resistance, and Renal Function
Knight, S. F., & Imig, J. D. (2007) · Microcirculation · doi:10.1080/10739680701283018 · Cited by 97
“Visceral obesity has been linked directly with the development of insulin resistance by way of increased free fatty acid release as well as increased adipokine production [24, 37, 51].”
BackgroundFrom endocannabinoid profiling to ‘endocannabinoid therapeutics’
Ligresti, A., Petrosino, S., & Marzo, V. D. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.04.615 · Cited by 106
The Metabolic Syndrome, a Human Disease
Alemany, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042251 · Cited by 100
Caron‐Jobin, M., Morisset, A., Tremblay, A., Huot, C., Légaré, D., & Tchernof, A. (2011) · Obesity · doi:10.1038/oby.2011.90 · Cited by 98
“Central fat distribution is an important predictor of several metabolic disorders (14), but only two studies examined the relationship between vitamin D and measures of body fat distribution.”
BackgroundMiR-335, an Adipogenesis-Related MicroRNA, is Involved in Adipose Tissue Inflammation
Zhu, L., Chen, L., Shi, C., Xu, G., Xu, L., Zhu, L., Guo, X., Ni, Y., Cui, Y., & Ji, C. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9708-3 · Cited by 88
“Visceral adipose tissue accumulation is associated with increased mortality and risk for diabetes and insulin resistance, whereas subcutaneous adipose tissue generally serves as a storage organ [14, 15].”
Stanley, T. L., Feldpausch, M. N., Oh, J.-H., Branch, K. L., Lee, H., Torriani, M., & Grinspoon, S. K. (2014) · JAMA · doi:10.1001/jama.2014.8334 · Cited by 94
Decreased expression of CD36 in circumvallate taste buds of high-fat diet induced obese rats
Zhang, X.-J., Zhou, L., Ban, X., Liu, D., Jiang, W., & Liu, X.-M. (2010) · Acta Histochemica · doi:10.1016/j.acthis.2010.09.007 · Cited by 99
O'Connor, M. Y., Thoreson, C. K., Ricks, M., Courville, A. B., Thomas, F., Yao, J., Katzmarzyk, P. T., & Sumner, A. E. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0026 · Cited by 88
“Central obesity and visceral adiposity in particular are more predictive of cardiometabolic disease than BMI.(16,29) At a lower BMI and WC than African Americans, we found that African immigrants had more VAT as well as a higher rate of diabetes and prediabetes.”
Management of Obesity in Cardiovascular Practice
Després, J.-P., Carpentier, A. C., Tchernof, A., Neeland, I. J., & Poirier, P. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.05.035 · Cited by 87
Self-citationMorelli, A., Comeglio, P., Filippi, S., Sarchielli, E., Vignozzi, L., Maneschi, E., Cellai, I., Gacci, M., Lenzi, A., Vannelli, G. B., et al. (2013) · The Prostate · doi:10.1002/pros.22584 · Cited by 87
“Features of this syndrome include: insulin resistance (hyperinsulinemia, impaired glucose tolerance, and type 2 diabetes mellitus), dyslipidemia (hypertriglyceridemia and low serum high-density lipoprotein cholesterol), visceral fat accumulation, and hypertension [1].”
BackgroundLupoli, R., Minno, M. N. D. D., Guidone, C., CEFALO, C. M. A., Capaldo, B., Riccardi, G., & Mingrone, G. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.187 · Cited by 95
Ji, Y. S., Cheng, B., Xu, Z., Ye, H., Lu, W., Luo, X., Fu, S., & Fang, X. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.03.019 · Cited by 89
Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies
the ARIA group, Bousquet, J. J., Cristol, J., Czarlewski, W., Antó, J. M., Martineau, A. R., Haahtela, T., Fonseca, S. C., Iaccarino, G., Blain, H., et al. (2020) · Clinical and Translational Allergy · doi:10.1186/s13601-020-00362-7 · Cited by 88
“IR is a key component of the metabolic syndrome, a clustering of at least three of the five following medical conditions: abdominal obesity [62], high blood pressure [63], high blood sugar, high serum triglycerides, and low serum high-density lipoprotein (HDL) [64].”
BackgroundOverweight, Obesity, and CVD Risk: a Focus on Visceral/Ectopic Fat
Chartrand, D. J., Murphy-Després, A., Alméras, N., Lemieux, I., Larose, É., & Després, J. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-00996-x · Cited by 96
Self-citationSteroidogenesis—Adrenal Cell Signal Transduction
Gallo‐Payet, N., & Battista, M. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130050 · Cited by 74
Lymphocytes in the Peritoneum Home to the Omentum and Are Activated by Resident Dendritic Cells
Carlow, D. A., Gold, M. R., & Ziltener, H. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900409 · Cited by 93
“Visceral obesity is a good correlate of metabolic syndrome (44) and proinflammatory dialogue between lymphomyeloid cells and adipocytes (35), especially in visceral adipose tissues (44) including the omentum (45, 46), is thought to participate in the metabolic disturbances associated with obesity (37–39).”
Backgroundvan Beek, L., van Klinken, J. B., Pronk, A. C. M., van Dam, A. D., Dirven, E., Rensen, P. C. N., Koning, F., Willems van Dijk, K., & van Harmelen, V. (2015) · Diabetologia · doi:10.1007/s00125-015-3594-8 · Cited by 79
“mellitus and cardiovascular disease [1, 2].”
Rittig, K., Staib, K., Machann, J., Bøttcher, M., Peter, A., Schick, F., Claussen, C. D., Stefan, N., Fritsche, A., Häring, H., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1128-3 · Cited by 90
“In particular, ectopic fat stores such as liver fat (LF) and visceral adipose tissue (VAT) show a significant association with whole body insulin sensitivity [1].”
BackgroundGirerd, N., Pîbarot, P., Fournier, P., Daleau, P., Voisine, P., O’Hara, G. E., Després, J., & Mathieu, P. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp091 · Cited by 94
“To this effect, it has been demonstrated that, in contrast to subcutaneous fat, the visceral fat produces a large amount of inflammatory cytokines, including IL-6.(26) In turn, IL-6 stimulates the hepatic synthesis of C-reactive protein.”
BackgroundSelf-citationTsartsou, E., Proutsos, N., Castanas, E., & Kampa, M. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00006 · Cited by 84
“Two or more categories were extracted from each study: (1) Normal (control) diet (CD) or Control Sample (CS); (2) Intervention including Mediterranean Diet with olive oil containing low or high polyphenols; (3) Intervention including olive oil with a low (<60 mg/kg) polyphenol content (LPC); (4) Diet including differe…”
MethodImpact of obesity on total and cardiovascular mortality—fat or fiction?
Cepeda-Valery, B., Pressman, G. S., Figueredo, V. M., & Romero‐Corral, A. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.209 · Cited by 90
“Several hypotheses have been proposed to explain the association between visceral fat and metabolic risk factors, such as insulin resistance and hypertriglyceridemia”
BackgroundMilone, M., Lupoli, R., Maietta, P., Minno, A. D., Bianco, P., Ambrosino, P., Coretti, G., Milone, F., Minno, M. N. D. D., & Musella, M. (2015) · International Journal of Surgery · doi:10.1016/j.ijsu.2014.12.025 · Cited by 86
“Severe obesity is one of the major health problems in Western Countries [1,2] and, besides nutritional and pharmacological”
BackgroundTan, S., Wang, J., Cao, L., Guo, Z., & Wang, Y. (2016) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12217 · Cited by 78
“This decrease is an encouraging outcome as the fat deposit in this area has been recognized as a strong risk factor for heart disease, type 2 diabetes and the metabolic syndrome (Despr es & Lemieux, 2006; Canoy et al., 2007).”
BackgroundYamaguchi, N., Mahbub, M., Takahashi, H., Hase, R., Ishimaru, Y., Sunagawa, H., Amano, H., Kobayashi‐Miura, M., Kanda, H., Fujita, Y., et al. (2017) · Environmental Health and Preventive Medicine · doi:10.1186/s12199-017-0642-7 · Cited by 92
“org/publicdomain/ze lifestyle-related diseases [3, 4], and early detection of such factors is important for prevention of the diseases.”
BackgroundThe Importance of Brown Adipose Tissue
(2009) · New England Journal of Medicine · doi:10.1056/nejmc091009 · Cited by 84
Natural and semisynthetic protein tyrosine phosphatase 1B (PTP1B) inhibitors as anti-diabetic agents
Wang, L., Jiang, B., Wu, N., Wang, S., & Shi, D. (2015) · RSC Advances · doi:10.1039/c5ra01754h · Cited by 89
Candi, E., Tesauro, M., Cardillo, C., Lena, A. M., Schinzari, F., Rodia, G., Sica, G. S., Gentileschi, P., Rovella, V., Annicchiarico‐Petruzzelli, M., et al. (2018) · Biochemical Journal · doi:10.1042/bcj20170604 · Cited by 85
Maffeis, C., Manfredi, R. M., Trombetta, M., Sordelli, S., Storti, M., Benuzzi, T., & Bonadonna, R. C. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2089 · Cited by 105
“The relationship between insulin resistance and visceral and sc fat distribution is affected by puberty (16, 17).”
BackgroundAbdominal Obesity and Metabolic Syndrome Burden in Adolescents—Penn State Children Cohort Study
He, F., Rodriguez-Colon, S. M., Fernández‐Mendoza, J., Vgontzas, A. N., Bixler, E. O., Berg, A. S., Kawasawa, Y. I., Sawyer, M. D., & Liao, D. (2014) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2014.07.009 · Cited by 94
“Recently, it has also been recognized that excessive fat accumulation in abdominal region is associated with cardiometabolic risk (5).”
BackgroundMitterberger, M. C., Lechner, S., Mattesich, M., & Zwerschke, W. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glt043 · Cited by 84
Gruson, E., Montaye, M., Kee, F., Wagner, A., Bingham, A., Ruidavets, J., Haas, B., Evans, A., Ferrières, J., Ducimetière, P., et al. (2009) · Heart · doi:10.1136/hrt.2009.171447 · Cited by 85
“At inclusion, subjects were considered as having a history of coronary disease at entry if they had any one of: (1) myocardial infarction and/or angina pectoris diagnosed by a physician; (2) electrocardiographic evidence of myocardial infarction, defined as major or moderate Q waves coded using the Minnesota system; (…”
MethodAblation of endothelial VEGFR1 improves metabolic dysfunction by inducing adipose tissue browning
Seki, T., Hosaka, K., Fischer, C., Lim, S., Andersson, P., Abe, M., Iwamoto, H., Gao, Y., Wang, X., Fong, G., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20171012 · Cited by 89
“20171012 611 IntroductIon Obesity and its related metabolic disorders are major health issues affecting all age groups (Spiegelman and Flier, 2001; Zimmet et al., 2001; Després and Lemieux, 2006).”
BackgroundHawkins, K. L., Zhang, L., Ng, D. K., Althoff, K. N., Palella, F. J., Kingsley, L., Jacobson, L. P., Margolick, J. B., Lake, J. E., Brown, T. T., et al. (2018) · AIDS · doi:10.1097/qad.0000000000001829 · Cited by 92
“inflammation and immune activation [40].”
Borel, A., Nazare, J., Smith, J., Alméras, N., Tremblay, A., Bergeron, J., Poirier, P., & Després, J. (2012) · Obesity · doi:10.1038/oby.2011.396 · Cited by 84
“IntroductIon Excess visceral adiposity, whose prevalence has increased dramatically (1), is recognized as a major correlate of a cluster of cardiometabolic abnormalities leading to increased cardiovascular morbidity and mortality (2,3).”
BackgroundSelf-citationHolly, J. M. P., Biernacka, K. M., & Perks, C. M. (2019) · Cells · doi:10.3390/cells8101207 · Cited by 91
“In humans, there is a marked functional distinction between adipocytes in different anatomical regions with visceral adipocytes being much more closely associated with metabolic syndrome, type 2 diabetes, and cardiovascular risk [137].”
BackgroundLiu, S., Ma, X., Zhao, J., Du, S.-X., Zhang, J., Dong, M., & Xin, Y. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01288-6 · Cited by 84
Westgate, C. S. J., Botfield, H. F., Alimajstorovic, Z., Yiangou, A., Walsh, M. D., Smith, G., Singhal, R., Mitchell, J., Grech, O., Markey, K. A., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.145346 · Cited by 87
“Obesity is a feature of metabolic disease, associated with insulin resistance and hyperleptinemia (40).”
Borch, K. H., Brækkan, S. K., Mathiesen, E. B., Njølstad, I., Wilsgaard, T., Störmer, J., & HANSEN, J. ‐. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03234.x · Cited by 95
Effects of xylitol on metabolic parameters and visceral fat accumulation
Amo-Shiinoki, K., Arai, H., Uebanso, T., Fukaya, M., Koganei, M., Sasaki, H., Yamamoto, H., Taketani, Y., & Takeda, E. (2011) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.10-111 · Cited by 89
Mineralocorticoid receptors in the metabolic syndrome
Zennaro, M., Caprio, M., & Fève, B. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.05.006 · Cited by 88
Hämäläinen, P., Saltevo, J. T., Kautiainen, H., Mäntyselkä, P. T., & Vanhala, M. J. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-116 · Cited by 88
“Insulin resistance has been the most accepted and unifying hypothesis to describe the pathophysiology of the metabolic syndrome [1].”
BackgroundCaspase Induction and BCL2 Inhibition in Human Adipose Tissue
Tinahones, F. J., Coín‐Aragüez, L., Murri, M., Oliva‐Olivera, W., Torres, M. D. M., Barbarroja, N., Gómez‐Huelgas, R., Malagón, M. M., & Bekay, R. E. (2013) · Diabetes Care · doi:10.2337/dc12-0194 · Cited by 86
Relationships and Inflammation across the Lifespan: Social Developmental Pathways to Disease
Fagundes, C. P., Bennett, J. M., Derry, H. M., & Kiecolt‐Glaser, J. K. (2011) · Social and Personality Psychology Compass · doi:10.1111/j.1751-9004.2011.00392.x · Cited by 75
DeFilipp, Z., Duarte, R. F., Snowden, J. A., Majhail, N. S., Greenfield, D. M., Miranda, J. L., Arat, M., Baker, K. S., Burns, L. J., Duncan, C. N., et al. (2017) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.203 · Cited by 84
“accumulation independently confers cardiometabolic risk [29, 30].”
The Esophageal Epithelial Barrier in Health and Disease
Blevins, C. H., Iyer, P. G., Vela, M. F., & Katzka, D. A. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.06.035 · Cited by 84
Bariatric surgery and diabetes remission: Sleeve gastrectomy or mini-gastric bypass?
Milone, M., Minno, M. N. D. D., Leongito, M., Maietta, P., Bianco, P., Taffuri, C., Gaudioso, D., Lupoli, R., Savastano, S., Milone, F., et al. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i39.6590 · Cited by 86
Adipokines and insulin action: A sensitive issue
Knights, A. J., Funnell, A. P. W., Pearson, R. C. M., Crossley, M., & Bell-Anderson, K. S. (2014) · Adipocyte · doi:10.4161/adip.27552 · Cited by 100
“It is often associated with a low-grade state of chronic inflammation, and is causally linked to metabolic disorders such as insulin resistance, type 2 diabetes mellitus (T2DM), and cardiovascular disease.(2,3) The inextricable link between adiposity, insulin resistance, and the metabolic syndrome has been the subject…”
BackgroundLymphatic system: a vital link between metabolic syndrome and inflammation
Chakraborty, S., Zawieja, S. D., Wang, W., Zawieja, D. C., & Muthuchamy, M. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05752.x · Cited by 89
Tian, Z., Miyata, K., Tazume, H., Sakaguchi, H., Kadomatsu, T., Horio, E., Takahashi, O., Komohara, Y., Araki, K., Hirata, Y., et al. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.01.004 · Cited by 88
C1q/TNF‐related protein‐1 functions to protect against acute ischemic injury in the heart
Yuasa, D., Ohashi, K., Shibata, R., Mizutani, N., Kataoka, Y., Kambara, T., Uemura, Y., Matsuo, K., Kanemura, N., Hayakawa, S., et al. (2015) · The FASEB Journal · doi:10.1096/fj.15-279885 · Cited by 88
“Obesity is closely associated with the development of metabolic syndrome, type 2 diabetes, dyslipidemia, and hypertension, and obesity-related complications are well-established risk factors for cardiovascular diseases, including ischemic heart disease (2, 3).”
BackgroundJoris, P. J., Plat, J., Kusters, Y. H. A. M., Houben, A. J. H. M., Stehouwer, C. D. A., Schalkwijk, C. G., & Mensink, R. P. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.143552 · Cited by 86
A Review on the Protective Effects of Honey against Metabolic Syndrome
Ramli, N. Z., Chin, K., Zarkasi, K. A., & Ahmad, F. (2018) · Nutrients · doi:10.3390/nu10081009 · Cited by 91
“Eventually, excess FFA in the liver will be used to produce TG that will be incorporated into VLDL.”
BackgroundInfluentialAhmed, M., Kumari, N., Mirgani, Z., Saeed, A., Ramadan, A., Ahmed, M. H., & Almobarak, A. O. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00965-2 · Cited by 88
“Insulin resistance leads to a progression from hyperinsulinemia to glucose intolerance and type 2 diabetes mellitus [27].”
BackgroundOverall Obesity and Abdominal Adiposity as Predictors of Mortality in U.S. White and Black Adults
Reis, J. P., Araneta, M. R. G., Wingard, D. L., Macera, C. A., Lindsay, S. P., & Marshall, S. J. (2009) · Annals of Epidemiology · doi:10.1016/j.annepidem.2008.10.008 · Cited by 82
“As a consequence of the potentially increased atherogenicity of visceral fat (11), this would suggest that at the same level of obesity, black adults may have a lower risk of morbidity and mortality compared with whites.”
Resistin: a hormone which induces insulin resistance is increased in normal pregnancy
Nien, J. K., Mazaki‐Tovi, S., Romero, R. J., Kusanovic, J. P., Erez, O., Gotsch, F., Pineles, B. L., Friel, L. A., Espinoza, J., Gonçalves, L. F., et al. (2007) · Journal of Perinatal Medicine · doi:10.1515/jpm.2007.122 · Cited by 97
Song, H., Chu, Q., Xu, D., Xu, Y., & Zheng, X. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b05177 · Cited by 90
Current and Future Drug Targets in Weight Management
Witkamp, R. F. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0341-1 · Cited by 90
“For any given amount of total body fat, those individuals with a predominant excess of intra-abdominal or visceral adipose tissue are at substantially higher risk of becoming insulin resistant or getting any of the other features of the metabolic syndrome (4,7,8).”
BackgroundFasting-mimicking diet prevents high-fat diet effect on cardiometabolic risk and lifespan
Mishra, A. K., Mirzaei, H., Guidi, N., Vinciguerra, M., Mouton, A., Linardić, M., Rappa, F., Barone, R., Navarrete, G., Wei, M., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00469-6 · Cited by 84
Revitalizing T cells: breakthroughs and challenges in overcoming T cell exhaustion
Wu, Y., Wu, Y., Gao, Z., Yu, W., Zhang, L., & Zhou, F. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02327-3 · Cited by 89
Oxidative Stress: Molecular Mechanisms, Diseases, and Therapeutic Targets
Qin, Y., Qian, C., Li, W., Wang, Q., Sheng, Q., Chen, Z., Zhang, W., Li, W., Ge, G., Yan, Z., et al. (2026) · MedComm · doi:10.1002/mco2.70600 · Cited by 94
Caloric restriction and chronic inflammatory diseases
González, O. A., Tobia, C. M., Ebersole, J. L., & Novak, M. J. (2011) · Oral Diseases · doi:10.1111/j.1601-0825.2011.01830.x · Cited by 89
“This is particularly exciting given the fact that chronic inflammation in adipose tissue is implicated in metabolic syndrome and obesity (Despres and Lemieux, 2006).”
BackgroundHuang, Z. H., Manickam, B., Ryvkin, V., Zhou, X. J., Fantuzzi, G., Mazzone, T., & Sam, S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2697 · Cited by 79
Rittig, K., Dolderer, J. H., Balletshofer, B. M., Machann, J., Schick, F., Meile, T., Küper, M. A., Stock, U. A., Staiger, H., Machicao, F. E., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2481-9 · Cited by 89
“Mainly ectopic fat stores such as liver fat, but also visceral adipose tissue (VAT), show a significant association with whole-body insulin sensitivity [3].”
Immunomodulation by food: promising concept for mitigating allergic disease?
Wichers, H. (2009) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-009-2838-1 · Cited by 79
“diseases, neoplastic malformations, and metabolic syndrome—chronic inflammatory processes are involved, possibly causally, in the development of subsequent related health problems, also suggesting an important role for immune interventions [5–9].”
BackgroundCakir, H., Heus, C., van der Ploeg, T. J., & Houdijk, A. P. J. (2015) · International Journal of Colorectal Disease · doi:10.1007/s00384-015-2174-1 · Cited by 88
HEINONEN, I. H. A., Rinne, P., Ruohonen, S., Ruohonen, S., Ahotupa, M. O., & Savontaus, E. (2014) · Acta Physiologica · doi:10.1111/apha.12253 · Cited by 92
Bozorgmanesh, M., Hadaegh, F., & Azizi, F. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-100 · Cited by 81
“With the introduction of the MetS, the abdominal obesity was recognized as a clinically measurable (although imperfect) entity [8,16-18].”
Backgroundon behalf of the RISC Investigators, Ferrannini, E., Natali, A., Muscelli, E., Nilsson, P. M., Golay, A., Laakso, M., Beck-Nielsen, H., & Mari, A. (2011) · Diabetologia · doi:10.1007/s00125-011-2112-x · Cited by 80
“Possibly, a higher waist-to-hip ratio, which reflects a more central distribution of body fat, carries risk of dysglycaemia through subclinical inflammation [26, 28, 29]; fasting glycaemia, on the other hand, may mark the presence of more marked hepatic insulin resistance [30] and relative hyperglucagonaemia [31, 32].”
BackgroundThe Usefulness of Anthropometric Indices to Identify the Risk of Metabolic Syndrome
Suliga, E., Ciesla, E., Głuszek-Osuch, M., Rogula, T., Głuszek, S., & Kozieł, D. (2019) · Nutrients · doi:10.3390/nu11112598 · Cited by 80
Relationship between Lung Function and Metabolic Syndrome
Chen, W., Wang, C., Wu, L., Kao, T., Chan, J. Y., Chen, Y.-J., Yang, Y., Chang, Y., & Peng, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108989 · Cited by 85
“Given that various distributions of abdominal and visceral fat accumulation were noted in different race populations and genders [25], our viewpoint of the varying weight of each component in different racial groups was confirmed.”
BackgroundWald, D., Teucher, B., Dinkel, J., Kaaks, R., Delorme, S., Boeing, H., Seidensaal, K., Meinzer, H., & Heimann, T. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23775 · Cited by 80
Silvestri, C., & Marzo, V. D. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.704019 · Cited by 91
“and not subcutaneous, adiposity that is closely associated with several aspects of the metabolic syndrome [32,33].”
BackgroundGeneral and Abdominal Adiposity and Risk of Stroke in Chinese Women
Zhang, X., Shu, X.-O., Gao, Y.-T., Yang, G., Li, H., & Zheng, W. (2009) · Stroke · doi:10.1161/strokeaha.108.539692 · Cited by 79
Obesity associated disease risk: the role of inherent differences and location of adipose depots
Hill, J. H., Solt, C., & Foster, M. T. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0012 · Cited by 79
UV modulation of subcutaneous fat metabolism
Kim, E. J., Kim, Y. K., Kim, J. E., Kim, S., Kim, M.-K., Park, C.-H., & Chung, J. H. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.106 · Cited by 79
Qiao, Y., Zhang, Z., Zhai, Y., Yan, X., Zhou, W., Liu, H., Guan, L., & Peng, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.805827 · Cited by 85
“Excessive abdominal fat increases the risk of metabolic syndrome, which is closely associated with numerous chronic diseases, such as cardiovascular disease, hypertension, dyslipidemia, non-alcoholic fatty liver disease (NAFLD), diabetes, and cancer (Despres and Lemieux, 2006).”
BackgroundQiu, L., Gao, C., Wang, H., Ren, Y., Li, J., Li, M., Du, X., Li, W., & Zhang, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1216708 · Cited by 87
In Central Obesity, Weight Loss Restores Platelet Sensitivity to Nitric Oxide and Prostacyclin
Russo, I., Traversa, M., Bonomo, K., De Salve, A., Mattiello, L., Del Mese, P., Doronzo, G., Cavalot, F., Trovati, M., & Anfossi, G. (2010) · Obesity · doi:10.1038/oby.2009.302 · Cited by 76
“Actually, abdominal fat deposition is characterized by a greater ability to release cytokines and free fatty acids than subcutaneous fat deposition, and therefore is more deeply involved in the pathogenesis of both atherothrombosis and insulin resistance (5,6).”
BackgroundResistance training for obese, type 2 diabetic adults: a review of the evidence
Hills, A. P., Shultz, S. P., Soares, M. J., Byrne, N. M., Hunter, G. R., King, N. A., & Misra, A. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00692.x · Cited by 73
“The increasing prevalence of obesity and the associated dysfunctional state of adipose tissue are the major contributors to the incidence of T2DM (5).”
BackgroundKadakia, M. B., Fox, C. S., Scirica, B. M., Murphy, S. A., Bonaca, M. P., & Morrow, D. A. (2011) · Heart · doi:10.1136/heartjnl-2011-300231 · Cited by 83
“Visceral fat has been associated with the development of dyslipidaemia, insulin resistance, hypertension and secretion of proinflammatory cytokines, all of which can promote atherogenesis.(28) However, this may vary among different ethnic groups.”
Background
Metadata
- Authors
- Després, J.-P., & Lemieux, I.
- Venue
- Nature
- Published
- 2006-12-13
- Volume
- 444
- Issue
- 7121
- Pages
- 881-887
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1991334358
- Semantic Scholar
- 12903a24428f6c6024aed0c7b8de08306f8b15ff
- Cited by
- 4,354
- References
- 94
- Citations by year
- 2026: 146 · 2025: 172 · 2024: 216 · 2023: 209 · 2022: 259 · 2021: 259 · 2020: 223 · 2019: 231 · 2018: 236 · 2017: 225 · 2016: 265 · 2015: 236 · 2014: 270 · 2013: 269 · 2012: 241
- FWCI
- 21.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- abdominal obesity, metabolic syndrome, insulin resistance, diabetes risk, cardiovascular risk, inflammation, risk assessment algorithm, diagnostic criteria
- MeSH terms
- Abdomen, Cardiovascular Diseases, Humans, Obesity, Risk Assessment, Metabolic Syndrome, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.